Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae

Applied and Environmental Microbiology

Volumn 64, Issue 2, 1998, Pages 564-568

  Brandão, Rogelio L ^a   Castro, Ieso M ^a   Bambirra, Eduardo A ^b   Amaral, Sheila C ^a   Fietto, Luciano G ^a   Tropia, Maria José M ^a   Neves, Maria José ^b   Dos Santos, Raquel G ^b   Gomes, Newton C M ^b   Nicoli, Jacques R ^b  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; CHOLERA TOXIN; CHOLERA TOXIN B SUBUNIT; CYCLIC AMP; GLUCOSE; TREHALASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; ENZYME ACTIVATION; GASTROENTERITIS; INTERNALIZATION; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; VIBRIO CHOLERAE; YEAST CELL;

ANIMALIA; CLOSTRIDIUM DIFFICILE; MAMMALIA; MARTES PENNANTI; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; VIBRIO CHOLERAE;

EID: 0031938213     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.64.2.564-568.1998     Document Type: Article

References (23)

1. Berg, R. D. 1996. The indigenous gastrointestinal microflora. Trends Microbiol. 4:430-435.
2. Buts, J. P., G. Corthier, and M. Delmee. 1993. Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants. J. Pediatr. Gastroenterol. Nutr. 16:419-425.
3. Chapoy, P. 1985. Traitement des diarrhées aiguës infantiles: essai controlé de Saccharomyces boulardii. Ann. Pediatr. 32:561-563.
4. Chia, J. K. S., S. M. Chan, and H. Goldstein. 1995. Baker's yeast as adjunctive therapy for relapses of Clostridium difficile diarrhea. Clin. Infect. Dis. 20:1581.
5. Cuatrecasas, P. 1973. Interaction of Vibrio cholerae enterotoxin with cell membranes. Biochemistry 12:3547-3557.
6. Czerucka, D., I. Roux, and P. Rampal. 1994. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells. Gastroenterology 106:65-72.
7. Dias, R. S., E. A. Bambirra, M. E. Silva, and J. R. Nicoli. 1995. Protective effect of Saccharomyces boulardii against the cholera toxin in rats. Braz. J. Med. Biol. Res. 28:323-325.
8. Gill, D. M., and C. A. King. 1975. The mechanism of action of cholera toxin in pigeon crythrocyte lysates. J. Biol. Chem. 250:6424-6432.
9. Kaper, J. B., A. Fasano, and M. Trucksis. 1994. Toxins of Vibrio cholerae, p. 145-176. In I. K. Wachsmuth, P. A. Blake, and O. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. American Society for Microbiology, Washington, D.C.
10. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
11. Massot, J., M. Desconclois, and J. Astoin. 1982. Protection par Saccharomyces boulardii de la diarrhée à Escherichia coli du souriceau. Ann. Pharm. Fr. 40:13-15.
12. McFarland, L. V., and P. Bernasconi. 1993. Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microb. Ecol. Health Dis. 6:157-171.
13. Peret Filho, L. A., F. J. Penna, E. A. Bambirra, and J. R. Nicoli. Dose effect of oral Saccharomyces boulardii treatments on morbidity and mortality in immunosuppressed mice. J. Med. Microbiol., in press.
14. Pouthoulakis, C., C. P. Kelly, M. A. Joshi, N. Gao, C. J. O'Keane, I. Castiglioulo, and J. T. Lamont. 1993. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 104:1108-1115.
15. Rodrigues, A. C. P., R. M. Nardi, E. A. Bambirra, E. C. Vieira, and J. R. Nicoli. 1996. Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. J. Appl. Bacteriol. 81:251-256.
16. Schellenberg, D., A. Bonington, C. M. Champion, R. Lancaster, S. Webb, and J. Main. 1994. Treatment of Clostridium difficile diarrhoea with brewers yeast. Lancet 343:171.
17. Schlotterer, M., P. Bernasconi, F. Lebreton, and J. L. Touraine. 1987. Intérêt de Saccharomyces boulardii dans la tolérance digestive de la nutrition entérale à débit continu chez de brulé. Nutr. Clin. Metab. 1:31-34.
18. Surawicz, C. M., G. W. Elmer, P. Speelman, L. V. McFarland, J. Chinn, and G. Van Belle. 1989. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96:981-988.
19. Thevelein, J. M., and K. A. Jones. 1983. Reversibility characteristics of the glucose-induced trehalase activation associated with the breaking of dormancy in the yeast ascospores. Eur. J. Biochem. 136:583-587.
20. Thevelein, J. M., and M. Beullens. 1985. Cyclic AMP and stimulation of trehalase activity in yeast Saccharomyces cerevisiae by carbon sources, nitrogen sources and inhibitor of protein synthesis. J. Gen. Microbiol. 131:3199-3209.
21. Thevelein, J. M., M. Beullens, F. Honsshoven, G. Hobeeck, K. Detremerie, J. A. Den Hollander, and S. W. H. Jans. 1987. Regulation of the cAMP level in the yeast Saccharomyces cerevisiae: intracellular pH and the effect of membrane depolarizing compounds. J. Gen. Microbiol. 133:2191-2196.
22. Thevelein, J. M. 1991. Fermentable sugars and intracellular acidification as specific activators of the RAS-adenylate cyclase signalling pathway in yeast: the relationship to nutrient-induced cell cycle control. Mol. Microbiol. 5:1301-1307.
23. Vidon, N., B. Huchet, and J. C. Rambaud. 1986. Influence de Saccharomyces boulardii sur la sécrétion induite chez le rat par la toxine cholérique. Gastroenterol. Clin. Biol. 10:13-16.